WS #11501
Novartis agreed to buy Myricx Bio for up to $1.5 billion to strengthen its oncology pipeline.
Novartis acquires Myricx Bio
Novartis agreed to buy Myricx Bio for up to $1.5 billion to strengthen its oncology pipeline.
Novartis agreed to buy Myricx Bio for up to $1.5 billion to strengthen its oncology pipeline.
Novartis agreed to buy Myricx Bio for up to $1.5 billion to strengthen its oncology pipeline.